RecruitingNCT07105111

Effectiveness of valbenazine in adults with tardive dyskinesia

Medication studyAges 18+United StatesSchizophrenia

The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations: Bryant, United States · Chino, United States and 17 more locationsSee all locations and recruitment
Activities: Medication described in the protocol
Compensation: Payment and expense reimbursement have not been verified.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: August 29, 2025

Recruitment status: Recruiting
Enrollment listed in the registry: 100
Sponsor: Neurocrine Biosciences
Sponsor type: Biotech company
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 4
Locations: United States
Age range: Over 18 Years
Official registry ID: NCT07105111
Official title: Show the full official title
A Phase 4, Open-Label Study to Evaluate the Efficacy of Valbenazine on Clinician- and Patient-Reported Outcomes in Patients With Tardive Dyskinesia (TD) Who Remain Symptomatic While on Deutetrabenazine or After Discontinuing Prior TD Treatment With a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Need help understanding this study?

Leave your email and we’ll get in touch to discuss your questions and possible next steps.

Recruitment & locations

Recruiting

Bryant · Chino · Fresno

16 more locations

Long Beach
Orange
Redlands
San Diego
Bonita Springs
Hialeah
Miami
Orange City
Port Charlotte
Tampa
Augusta
Naperville
Omaha
Independence
Austin
Richmond

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Neurocrine Biosciences, a biotech company.

Does this study involve medication?

Yes. The study involves medication, including Valbenazine.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me